Image-guided Biopsy Market Trends and Overview
The market size of image-guided biopsy was valued at USD 2,266.21 million in 2022. It is projected to reach USD 3,386.68 million by 2030, exhibiting a compound annual growth rate (CAGR) of 5.15% during the forecast period from 2023 to 2030.
Image-guided biopsy refers to a medical procedure that utilizes imaging techniques to guide the precise extraction of tissue samples for diagnostic purposes. This market has witnessed significant growth and is expected to continue its upward trajectory in the coming years.
The increasing prevalence of cancer and other chronic diseases has led to a surge in the demand for accurate and minimally invasive diagnostic procedures. Image-guided biopsy offers several advantages over traditional biopsy methods, such as reduced patient discomfort, improved accuracy, and faster recovery times. These factors have contributed to the growing adoption of image-guided biopsy techniques, thereby driving market growth.
Furthermore, advancements in imaging technologies, such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound, have enhanced the precision and efficiency of image-guided biopsy procedures. These technological advancements have not only improved the diagnostic accuracy but have also expanded the range of applications for image-guided biopsy across various medical specialties.
Geographically, North America currently dominates the image-guided biopsy market, owing to the presence of well-established healthcare infrastructure, high healthcare expenditure, and a large patient population. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period. Factors such as increasing healthcare investments, rising awareness about early disease detection, and improving healthcare infrastructure in emerging economies are driving the market growth in this region.
In conclusion, the image-guided biopsy market is poised for substantial growth in the coming years. The increasing prevalence of chronic diseases, technological advancements in imaging techniques, and expanding healthcare infrastructure in emerging economies are key factors driving market expansion. As a result, the market is expected to reach USD 3,386.68 million by Furthermore, the rising demand for minimally invasive procedures and the growing adoption of image-guided biopsies by healthcare professionals are also contributing to the market's growth.
Get Free Sample Report @ https://www.snsinsider.com/sample-request/2859
KEY MARKET SEGMENTATION:
- Vacuum Assisted Biopsy
- Core Needle
- Fine Needle
By Image Guided Technology:
By End User:
- Hospitals And Clinics
- Ambulatory Surgical Centers
- Research and Academic Institutes
Major Players Listed in the Report are as Follows:
Ethicon Endo-Surgery, Intact Medical Corporation, Galini SRL, Hologic Inc., Leica Biosystems Nussloch GmbH, C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule Medical Devices LLC. & Other players
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Akash Anand – Head of Business Development & Strategy,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),